Business Segments · Net Sales

Health & Science Technologies — Net Sales

IDEX Health & Science Technologies — Net Sales decreased by 2.3% to $398.40M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 16.7%, from $341.50M to $398.40M. Over 4 years (FY 2021 to FY 2025), Health & Science Technologies — Net Sales shows an upward trend with a 7.5% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityModerate
First reportedQ1 2013
Last reportedQ1 2026Apr 29, 2026
Rolls up toTotal Revenue

How to read this metric

An increase indicates growing demand for the segment's specialized products, while a decrease may signal market saturation or competitive pressure.

Detailed definition

Represents the total revenue generated from the sale of products and services within the Health and Science Technologies...

Peer comparison

Comparable to revenue metrics for life science instrumentation or medical component divisions at diversified industrial peers.

Metric ID: iex_segment_health_science_technologies_net_sales

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$275.00M$302.30M$294.10M$315.20M$326.00M$345.00M$353.00M$351.00M$339.50M$313.20M$312.70M$310.10M$303.80M$311.00M$373.20M$341.50M$365.30M$381.00M$407.70M$398.40M
QoQ Change+9.9%-2.7%+7.2%+3.4%+5.8%+2.3%-0.6%-3.3%-7.7%-0.2%-0.8%-2.0%+2.4%+20.0%-8.5%+7.0%+4.3%+7.0%-2.3%
YoY Change+18.5%+14.1%+20.0%+11.4%+4.1%-9.2%-11.4%-11.7%-10.5%-0.7%+19.3%+10.1%+20.2%+22.5%+9.2%+16.7%
Range$275.00M$407.70M
CAGR+8.1%
Avg YoY Growth+7.7%
Median YoY Growth+10.7%

Frequently Asked Questions

What is IDEX's health & science technologies — net sales?
IDEX (IEX) reported health & science technologies — net sales of $398.40M in Q1 2026.
How has IDEX's health & science technologies — net sales changed year-over-year?
IDEX's health & science technologies — net sales increased by 16.7% year-over-year, from $341.50M to $398.40M.
What is the long-term trend for IDEX's health & science technologies — net sales?
Over 4 years (2021 to 2025), IDEX's health & science technologies — net sales has grown at a 7.5% compound annual growth rate (CAGR), from $1.12B to $1.50B.
What does health & science technologies — net sales mean?
The total revenue earned by the Health and Science Technologies business unit.